Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®
Clinical trial NCT04209400 · COMPLETED
Trial details
- NCT number
- NCT04209400
- Sponsor
- VBI Vaccines Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-18
- Primary completion
- 2015-04-20
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.